Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 04, 2021

SELL
$134.22 - $202.37 $626,807 - $945,067
-4,670 Closed
0 $0
Q1 2021

May 04, 2021

BUY
$140.25 - $196.86 $406,444 - $570,500
2,898 Added 163.54%
4,670 $845,000
Q4 2020

Feb 08, 2021

SELL
$126.47 - $163.7 $1.34 Million - $1.74 Million
-10,630 Reduced 85.71%
1,772 $251,000
Q3 2020

Nov 05, 2020

SELL
$87.44 - $125.0 $939,717 - $1.34 Million
-10,747 Reduced 46.43%
12,402 $1.55 Million
Q2 2020

Aug 11, 2020

BUY
$58.39 - $89.31 $440,961 - $674,469
7,552 Added 48.42%
23,149 $2.07 Million
Q1 2020

May 12, 2020

BUY
$51.57 - $106.62 $804,337 - $1.66 Million
15,597 New
15,597 $972,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Migdal Insurance & Financial Holdings Ltd. Portfolio

Follow Migdal Insurance & Financial Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.